The global single-use assemblies market is witnessing robust growth, driven by the rapid transformation of biopharmaceutical manufacturing processes. Valued at USD 2.63 billion in 2024, the market is projected to reach USD 4.89 billion by 2029, expanding at an impressive CAGR of 13.2%. This surge reflects a broader industry shift toward flexible, efficient, and contamination-free production systems that can meet the rising demand for biologics.
Single-use assemblies—pre-sterilized, disposable fluid paths used in bioprocessing—are becoming indispensable in modern manufacturing. These systems eliminate the need for cleaning and sterilization, significantly reducing turnaround times and operational costs. As pharmaceutical and biotechnology companies prioritize efficiency and speed-to-market, the adoption of single-use technologies continues to accelerate.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46226549
Key Market Drivers
- Increasing demand for biologics, including vaccines and monoclonal antibodies
- Growing preference for cost-effective and flexible manufacturing solutions
- Reduced risk of cross-contamination compared to traditional stainless-steel systems
- Expansion of contract manufacturing organizations (CMOs) and contract research organizations (CROs)
- Rising adoption in emerging markets with expanding biopharma infrastructure
Another critical factor fueling growth is the advancement in customizable and modular single-use solutions. Manufacturers are now offering tailored assemblies that can be easily integrated into existing workflows, enabling scalability and adaptability. This is particularly valuable in the production of personalized medicines and next-generation therapies.
Leading Companies Shaping the Market
Several global players are driving innovation and competition in the single-use assemblies space, including:
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Merck KGaA
- Danaher Corporation
- Avantor, Inc.
These companies are actively strengthening their market positions through collaborations, product innovations, and geographic expansions.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46226549
Company Insights
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific stands as a market leader in single-use assemblies, offering a comprehensive range of assemblies and related accessories. The company’s continuous investment in research and development underscores its commitment to innovation. With a strong global presence and expansion strategies targeting both developed and emerging markets, Thermo Fisher is well-positioned for sustained growth. However, its Life Sciences Solutions segment experienced a temporary slowdown in revenue during the first nine months of 2024, largely due to declining COVID-19-related demand.
Sartorius AG
Sartorius AG is known for its extensive portfolio of high-quality single-use assemblies catering to biopharmaceutical companies, CMOs, and CROs. The company’s customer-centric approach, combined with strong R&D investments, has significantly boosted its market share. Sartorius has also aggressively expanded its global footprint, establishing and enhancing facilities across key regions such as China, the US, Europe, and Asia. Its Bioprocess Solutions Division reported stable revenue in 2024, supported by recovery in consumables and growth in new therapy segments.
Merck KGaA
Merck KGaA remains a key player in the single-use assemblies market due to its robust product portfolio and strong manufacturing capabilities. The company’s global supply chain and focus on innovation make it a preferred partner for biopharmaceutical companies. Despite a short-term revenue decline in its Process Solutions segment—attributed to post-pandemic adjustments and customer destocking—Merck continues to invest in advanced single-use technologies and capacity expansion to strengthen its long-term position.
Market Trends and Opportunities
- Increasing adoption of single-use systems in cell and gene therapy production
- Growing investments in biomanufacturing infrastructure worldwide
- Rising focus on sustainability and waste management solutions
- Integration of automation and digital monitoring in bioprocessing
As the biopharmaceutical industry continues to evolve, single-use assemblies are playing a crucial role in enabling faster, safer, and more efficient production processes. Their flexibility and scalability make them particularly suitable for emerging therapeutic areas and small-batch manufacturing.
Conclusion
The single-use assemblies market is set for significant expansion, supported by strong demand for biologics and continuous technological advancements. With leading players like Thermo Fisher Scientific Inc., Sartorius AG, and Merck KGaA driving innovation, the market is poised to transform biopharmaceutical manufacturing. As companies increasingly adopt these systems to enhance efficiency and reduce risks, single-use assemblies will remain a cornerstone of the future of bioprocessing.
For more information, Inquire Now!